title: Comparison of concurrent complications of CKD by 2 risk categorization systems.
abstract: BACKGROUND
  Using both estimated glomerular filtration rate (eGFR) and proteinuria to classify the severity of chronic kidney disease (CKD) has been proposed. The utility of a staging system incorporating both eGFR and proteinuria for guiding the evaluation of concurrent CKD complications is not known.
  
  
  METHODS
  Cross-sectional analysis.
  
  
  METHODS
  30,528 participants in the US National Health and Nutrition Examination Survey conducted in 1988-1994 and 1999-2006 (n = 8,242 for hyperparathyroidism).
  
  
  METHODS
  Classification system that uses both eGFR and proteinuria (alternative) and a system that primarily uses eGFR (NKF-KDOQI [National Kidney Foundation's Kidney Disease Outcomes Quality Initiative]).
  
  
  RESULTS
  Prevalence of anemia, acidosis, hyperphosphatemia, hypoalbuminemia, hyperparathyroidism, and hypertension.
  
  
  METHODS
  GFR estimated from the CKD Epidemiology Collaboration (CKD-EPI) equation and proteinuria assessed using urine albumin-creatinine ratio.
  
  
  RESULTS
  Prevalences of hypoalbuminemia, hypertension, and hyperparathyroidism increased with more severe CKD using the NKF-KDOQI system. For example, the prevalence of hyperparathyroidism was 9.1%, 11.1%, 28.2%, and 72.5% for stages 1, 2, 3 and 4, respectively. Similarly, prevalences of anemia, acidosis, and hyperphosphatemia increased progressively from stage 2 through 4. With the alternative system, prevalences of anemia, hyperphosphatemia, hypertension, and hyperparathyroidism were lower in stage 3 than in stage 2. For example, the prevalence of hyperparathyroidism was 13.5%, 40.3%, 22.2%, and 63.4% for stages 1, 2, 3 and 4, respectively. Applying the alternative system, participants without each complication were more likely to be reclassified appropriately to lower stages (eg, overall net reclassification index of -6.5% for hyperparathyroidism). However, participants with complications (except for hypoalbuminemia) were more likely to be reclassified inappropriately to lower stages.
  
  
  CONCLUSIONS
  Use of a single creatinine measurement to estimate GFR and single measurement to assess albumin-creatinine ratio. Small number of participants with CKD stage 4.
  
  
  CONCLUSIONS
  The NKF-KDOQI system may better identify patients with certain concurrent CKD complications compared with systems using eGFR and proteinuria.
authors: Tufts Medical Center, Boston, MA 02111, USA. linker@tuftsmedicalcenter.org
authors: Lesley A
authors: LA
authors: Inker
authors: Marcello
authors: M
authors: Tonelli
authors: Brenda R
authors: BR
authors: Hemmelgarn
authors: Emily B
authors: EB
authors: Levitan
authors: Paul
authors: P
authors: Muntner
mesh_terms: D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000145:classification* / Q000150:complications* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012306:Risk